Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives
about
Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxidePharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology Group.Effects upon in-vivo nicotine metabolism reveal functional variation in FMO3 associated with cigarette consumptionInflammation in the setting of chronic allograft dysfunction post-kidney transplant: phenotype and genotypeProfound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children.In vitro approaches to studying the metabolism of new psychoactive compounds.Inter-individual variation in flavin-containing monooxygenase 3 in livers from Japanese: correlation with hepatic transcription factors.Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption.Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients.Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.Development of a physiologically based pharmacokinetic model to predict the effects of flavin-containing monooxygenase 3 (FMO3) polymorphisms on itopride exposure.Donors FMO3 polymorphisms affect tacrolimus elimination in Chinese liver transplant patients.Antioxidant-related gene polymorphisms associated with the cardio-ankle vascular index in young Russians.
P2860
Q33976014-947D584B-6CC7-48CB-A6B4-ADFF51FA7D8DQ34810063-BD1610F1-9D00-4615-98D0-95A030423E0EQ36093134-F64C0532-5A36-4AEE-A5CE-9301E7798261Q36824123-EB541F3B-240E-4463-A289-658B4E0518A2Q37872786-A7781E11-5763-447E-97EB-398B0F5FF249Q37889234-FE11C82E-E0EE-4FF8-881D-2D719A99E5FCQ38510442-A34F8DD4-4804-41F7-A80F-6AF8867BB4EDQ38729535-B02BC6D6-38D4-4E7D-9CFA-8270F05CA689Q40322487-931CB5ED-3B9F-4764-8C3A-C097F3378173Q43585637-570547A7-3C3D-46F1-8F84-60588D369F15Q48168817-CB99C3C1-A011-486F-AA26-9FA4143D3570Q50462011-1FC25964-B1DB-4FB5-ADDA-4AA8E1EC9198Q51350352-497B00C0-A1F9-4001-94C8-8EA2CC03C992
P2860
Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Genetic polymorphisms of human ...... lism and clinical perspectives
@ast
Genetic polymorphisms of human ...... lism and clinical perspectives
@en
Genetic polymorphisms of human ...... lism and clinical perspectives
@nl
type
label
Genetic polymorphisms of human ...... lism and clinical perspectives
@ast
Genetic polymorphisms of human ...... lism and clinical perspectives
@en
Genetic polymorphisms of human ...... lism and clinical perspectives
@nl
prefLabel
Genetic polymorphisms of human ...... lism and clinical perspectives
@ast
Genetic polymorphisms of human ...... lism and clinical perspectives
@en
Genetic polymorphisms of human ...... lism and clinical perspectives
@nl
P2860
P356
P1433
P1476
Genetic polymorphisms of human ...... lism and clinical perspectives
@en
P2093
Irfan M Hisamuddin
Vincent W Yang
P2860
P304
P356
10.2217/14622416.8.6.635
P407
P577
2007-06-01T00:00:00Z